Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

被引：0

作者：

Dimitrios Velissaris

George Dimopoulos

John Parissis

Zoi Alexiou

Nikolaos Antonakos

Dimitrios Babalis

Styliani Gerakari

Vassileios Kaldis

Pantelis Koutoukas

Malvina Lada

Konstantinos Leventogiannis

Ioannis Pantazopoulos

Antonios Papadopoulos

Eftihia Polyzogopoulou

Charalambos Gogos

Apostolos Armaganidis

Evangelos J. Giamarellos-Bourboulis

机构：

[1] University of Patras,Department of Internal Medicine and Department of Emergency Medicine

[2] National and Kapodistrian University of Athens,Second Department of Critical Care Medicine, Medical School

[3] National and Kapodistrian University of Athens,Department of Emergency Medicine, Medical School

[4] Thriasio Elefsis General Hospital,Second Department of Internal Medicine

[5] National and Kapodistrian University of Athens,Fourth Department of Internal Medicine, Medical School

[6] Larissa General Hospital Koutlibaneion-Triantafyllion,Department of Emergency Medicine

[7] Tzaneion Piraeus General Hospital,Department of Emergency Medicine

[8] Sismanogleion Athens General Hospital,Department of Emergency Medicine

[9] Sparti General Hospital,Department of Emergency Medicine

[10] Sismanogleion General Hospital,Second Department of Internal Medicine

[11] University of Thessaly,Department of Emergency Medicine, University General Hospital of Larissa, School of Medicine

来源：

Infectious Diseases and Therapy | 2020年 / 9卷

关键词：

Emergency department; Mortality; suPAR; Triage;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In light of the accumulating evidence on the negative predictive value of soluble urokinase plasminogen activator receptor (suPAR), a group of experts from the fields of intensive care medicine, emergency medicine, internal medicine and infectious diseases frame a position statement on the role of suPAR in the screening of patients admitted to the emergency department. The statement is framed taking into consideration existing publications and our own research experience. The main content of this statement is that sUPAR is a non-specific marker associated with a high negative predictive value for unfavourable outcomes; levels < 4 ng/ml indicate that it is safe to discharge the patient, whereas levels > 6 ng/ml are an alarming sign of risk for unfavourable outcomes. However, the suPAR levels should always be interpreted in light of the patient's history.

引用

页码：407 / 416

页数：9

共 56 条

[1]

Eugen-Olsen J(2015)suPAR: the unspecific marker for disease presence, severity and prognosis Int J Antimicrob Agents 46S S33-S34

[2]

Giamarellos-Bourboulis EJ(2018)uPAR/suPAR signaling in rheumatoid arthritis: shedding light on its mechanism of action Pharmacol Res 134 31-39

[3]

Dinesh P(2017)Prognostic role of circulating soluble uPAR in various cancers: a systematic review and meta-analysis Clin Lab 63 871-880

[4]

Rassol M(2004)Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer Med Res Rev 24 13-39

[5]

Liu KL(2015)Serum soluble urokinase plasminogen actvator receptor as a screening tool for the early diagnosis of hepatocellular carcinoma Liver Int 35 601-607

[6]

Fan JH(2015)Soluble urokinase receptor and chronic kidney disease N Engl J Med 373 1916-1925

[7]

Wu J(2020)Soluble urokinase receptor and acute kidney disease N Engl J Med 382 416-426

[8]

de Bock CE(2017)A tripartite complex of suPAR, APOL1 risk variants and α Nat Med 23 945-953

[9]

Wang Y(2019)β Sci Rep 9 13783-6

[10]

Chounta A(2019) mediates chronic kidney disease Scand J Traum Res Emerg Med 27 43-350

← 1 2 3 4 5 6 →